Frontiers in endocrinology, 14, 1085799
22 Continued research is required to evaluate the cardiovascular effects of resmetirom in patients with MASH, who face a higher risk of death from cardiovascular disease
Consistent, a post hoc analysis of the LEADER trial investigated the association between changes in albuminuria within the first year and subsequent cardiovascular and renal events
Although FDA-approved GLP-1s, like Wegovy, are available, Mochi offers compounded (custom-formulated) GLP-1 medications, which are not FDA approved
Supports a balanced metabolism and sustains energy levels for healthy weight management
Initial studies in rats caused concerns over GLP-1 RAs causing thyroid cancer, but human studies are less clear on whether it is a concern.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)